Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/19109
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPanoulas, V. F.en
dc.contributor.authorDouglas, K. M.en
dc.contributor.authorMilionis, H. J.en
dc.contributor.authorStavropoulos-Kalinglou, A.en
dc.contributor.authorNightingale, P.en
dc.contributor.authorKita, M. D.en
dc.contributor.authorTselios, A. L.en
dc.contributor.authorMetsios, G. S.en
dc.contributor.authorElisaf, M. S.en
dc.contributor.authorKitas, G. D.en
dc.date.accessioned2015-11-24T18:56:54Z-
dc.date.available2015-11-24T18:56:54Z-
dc.identifier.issn1462-0324-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/19109-
dc.rightsDefault Licence-
dc.subjectAge Factorsen
dc.subjectAgeden
dc.subjectAntihypertensive Agents/therapeutic useen
dc.subjectAntirheumatic Agents/therapeutic useen
dc.subjectArthritis, Rheumatoid/*complications/drug therapy/epidemiologyen
dc.subjectCross-Sectional Studiesen
dc.subjectEngland/epidemiologyen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectHypertension/drug therapy/epidemiology/*etiologyen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectPrevalenceen
dc.subjectRisk Factorsen
dc.subjectSeverity of Illness Indexen
dc.titlePrevalence and associations of hypertension and its control in patients with rheumatoid arthritisen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1093/rheumatology/kem169-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/17704521-
heal.identifier.secondaryhttp://rheumatology.oxfordjournals.org/content/46/9/1477.full.pdf-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2007-
heal.abstractOBJECTIVES: Rheumatoid arthritis (RA) associates with excessive cardiovascular morbidity and mortality. Hypertension (HT) contributes significantly to the development of cardiovascular disease (CVD). Little is known about the factors that influence blood pressure (BP) in patients with RA. In this study, we assessed the prevalence of HT in a secondary care cohort of RA patients, and aimed to identify factors associated with its presence and inadequate control. METHODS: A total of 400 consecutive RA patients were studied. HT was defined as systolic BP >/=140 mmHg and/or diastolic BP >/=90 mmHg or current use of antihypertensive drugs. The association of HT with several demographic and RA-related factors, comorbidities and drugs was evaluated using logistic regression. RESULTS: HT was present in 282 (70.5%) patients. Of those, 171 (60.6%) received anti-hypertensive therapy, but 111 (39.4%) remained undiagnosed. Of those treated, only 37/171 (21.8%) were optimally controlled. Multivariable logistic regression revealed age (OR = 1.054, CI: 1.02 to 1.07, P = 0.001), body mass index [BMI (OR = 1.06, CI: 1.003-1.121, P = 0.038)] and prednisolone use (OR = 2.39, CI: 1.02-5.6, P = 0.045) to be independently associated with the presence of HT. BMI (OR = 1.11, CI: 1.02-1.21, P = 0.002) and the presence of CVD (OR = 4.01, CI: 1.27-12.69, P = 0.018) associated with uncontrolled HT. CONCLUSIONS: HT is highly prevalent in RA, under-diagnosed particularly in the young, and under-treated particularly in old RA patients with CVD. RA patients receiving steroids should be specifically targeted for screening and treatment; those with any cardiovascular comorbidity may require particularly aggressive monitoring and treatment strategies.en
heal.journalNameRheumatology (Oxford)en
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Panoulas-2007-Prevalence and assoc.pdf120.03 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons